Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,776 across all filing types
Latest filing 2022-05-31 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
金宇生物技术股份有限公司第十一届监事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of the resolution from the first meeting of the 11th Supervisory Board of JinYu Biotechnology Co., Ltd. It details the election of the chairman of the Supervisory Board and includes a brief biography of the elected chairman. There is no financial data, no mention of annual or quarterly reports, no audit information, and no regulatory certifications. The content focuses on board/management changes, specifically the election of a new Supervisory Board chairman. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication but a direct announcement of a management change.
2022-05-31 Chinese
金宇生物技术股份有限公司关于财务总监代行董事会秘书职责的公告
Board/Management Information Classification · 95% confidence The document is an announcement from a company regarding the appointment of the financial director to temporarily act as the board secretary. It discusses changes in senior management roles and does not contain financial statements, earnings data, or regulatory filings about financial results. The content focuses on management changes and appointments, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report or a notice of voting results, nor a regulatory filing or announcement of a report publication. Therefore, the classification is MANG with high confidence.
2022-05-31 Chinese
金宇生物技术股份有限公司2021年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2021 Annual General Meeting Resolution Announcement" for the company 金宇生物技术股份有限公司. It details the date and location of the AGM, attendance, voting results on various proposals including the 2021 annual report, financial report, profit distribution plan, election of board members, and other corporate governance matters. It also includes legal witness statements confirming the legality of the meeting and voting process. The content is focused on the resolutions passed at the AGM rather than the full annual report or financial statements themselves. The document length is about 5,831 characters, which is consistent with a detailed announcement of voting results and resolutions from an AGM. Therefore, this document fits best into the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-05-31 Chinese
金宇生物技术股份有限公司第十一届董事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the first meeting of the 11th Board of Directors of 金宇生物技术股份有限公司 (Jinyu Biotechnology Co., Ltd.). It details the election of the chairman, vice chairman, appointment of board committees, and senior management appointments. It includes voting results and biographies of the appointed individuals. There is no financial data, no discussion of financial results, no audit information, no shareholder voting results from a general meeting, and no mention of report publication or regulatory filings. The content is focused on board and management changes and appointments. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 3342 characters, which is consistent with a detailed announcement but not a full report.
2022-05-31 Chinese
经世律师事务所关于金宇生物技术股份有限公司2021年年度股东大会的法律意见书
Regulatory Filings
2022-05-31 Chinese
金宇生物技术股份有限公司独立董事关于第十一届董事会第一次会议相关事项的独立意见
Regulatory Filings
2022-05-31 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.